Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Theseus Pharmaceuticals Inc (NQ: THRX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 4.060 (3)
Ask (Size) 4.070 (1)
Prev. Close 4.060
Today's Range N/A - N/A
52wk Range 3.460 - 4.200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX
From Kahn Swick & Foti, LLC
Via Business Wire
Small-Cap Cancer Focused Theseus Pharmaceuticals Goes Private For Over $3.90/Share In Cash
Theseus Pharmaceuticals Inc (NASDAQ: THRX) on Friday, has entered into a definitive merger agreement whereby Concentra Biosciences LLC will acquire Theseus for a price per share of between $3.90 and... 
Via Benzinga

Performance

More News

Read More
THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Dow Jumps Over 500 Points; Home Depot Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Moves Higher; Beauty Health Shares Plunge
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Nasdaq Surges 2%; US Inflation Rate Slows In October
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Deciphera Pharmaceuticals Sees Renewed Competitive Edge After Theseus Pan-KIT Discontinuation: Analyst
Via Benzinga
Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
$2M Bet On Molecular Templates? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
Nasdaq Drops 50 Points; Wells Fargo Earnings Beat Views
Via Benzinga
Setback For Theseus Pharmaceuticals: Analysts Cut Price Targets But Remain Bullish On Stock
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Crude Oil Down 2%; Citigroup Profit Tops Estimates
Via Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Dow Jumps 150 Points; JPMorgan Posts Upbeat Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
Via Benzinga
PLUG Stock Alert: Plug Power Pops on Analyst Upgrade
Via InvestorPlace
Dose-Limiting Toxicities: Theseus Pharma Terminates THE-630 Study For Gastrointestinal Cancer
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.